![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Found 62 studies with search of: | "Acromegaly" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Glucose Tolerance in Acromegaly: The Influence of GH-Excess on Glucose Metabolism and Insulin Resistance
|
||||
2 | Recruiting |
The Treatment and Natural History of Acromegaly
|
||||
3 | Active, not recruiting |
Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
|
||||
4 | Not yet recruiting |
Use of Somatostatin Analogue Therapy as Primary Medical Treatment of Acromegaly
|
||||
5 | Recruiting |
Ultrasound Guided Sandostatin LAR Injection in Acromegaly
|
||||
6 | Completed |
Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
|
||||
7 | Active, not recruiting |
An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Patients With Acromegaly
|
||||
8 | Completed |
Safety and Efficacy of Long-Acting Repeatable Octreotide Acetate for Injectable Suspension Vs. Surgery in Treatment-naïve Patients With Acromegaly
|
||||
9 | Completed |
Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly
|
||||
10 | Recruiting |
Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
|
||||
11 | Completed |
Acute Application of Pegvisomant and Octreotide in Acromegaly
|
||||
12 | Recruiting |
Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
|
||||
13 | Completed |
Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
|
||||
14 | Completed |
Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR
|
||||
15 | Recruiting |
Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
|
||||
16 | Recruiting |
Physiopathology of Sodium Retention in Acromegaly
|
||||
17 | Completed |
Prediction of Tumor Shrinkage in Acromegaly
|
||||
18 | Recruiting |
Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly
|
||||
19 | Completed |
A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly
|
||||
20 | Completed |
Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly
|
![]() |
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
![]() |